Corporate actions this week: HDFC Bank, HCL Technologies to go ex-dividend, Sanginita Chemicals right issue and more

This week is packed with notable corporate actions. HDFC Bank, HCL Technologies, Oracle Financial Services Software, Laurus Labs, UCO Bank, and Bank of Maharashtra are set to go ex-dividend, while Ajooni Biotech and Sanginita Chemicals have their rights issue ex-date scheduled.

This week is packed with notable corporate actions. HDFC Bank, , , , , and Bank of Maharashtra are set to go ex-dividend, while Ajooni Biotech and have their rights issue ex-date scheduled.

On Monday, May 6, John Cockerill India (Rs 7/share) will go ex-dividend. Moving to Tuesday, May 7, HCL Technologies (Rs 18/share) and Oracle Financial Services Software (Rs 240/share) will follow suit.

On Wednesday, May 8, Laurus Labs (Rs 0.4/share) will trade ex-dividend, while GM Breweries (Rs 7/share) will do so on Thursday, May 9.

Aptech (Rs 4.5/share), Bank of Maharashtra (Rs 1.4/share), DCB Bank (Rs 1.25/share), Gujarat Intrux (Rs 7/share), HDFC Bank (Rs 19.5/share), Ramkrishna Forgings (Re 1/share), Transformers & Rectifiers (Rs 0.2/share), UCO Bank (Rs 0.28/share) will trade ex-dividend on Friday, May 10.

The ex-dividend date is when the price of the equity shares of a company gets adjusted for the dividend payout. It is one or two working days before the record date. All the shareholders whose names appear in the company's list by the end of the record date will be eligible to receive dividends.

Sonam Ltd (Rs 10 to Rs 5) will undergo a stock split on Friday, aiming to enhance stock liquidity.

Meanwhile, the record date for Ajooni Biotech and Sanginita Chemicals rights issues is set for Tuesday, May 7, 2024.

A rights issue is a prevalent form of corporate action where the company invites existing shareholders to buy additional shares in the company at a discounted price within the said period (the cut-off date).

However, as existing shareholders of the company, you do not have an obligation to buy additional shares. If you think the company has a flourishing business, you can apply for the rights issue and increase your stake within the company.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Chinese stocks hold bullish outlook, Gavekal Research says
24.09.2024 - 08:00
Levi Strauss warns of delay in hitting $10 billion sales goal, FT reports
24.09.2024 - 08:00
Oil firms evacuating US Gulf of Mexico staff as major hurricane looms
24.09.2024 - 07:00
Pro Research: Wall Street eyes Adobe's AI-driven growth
24.09.2024 - 06:00
Pro Research: Wall Street eyes Autodesk amid strategic shifts
24.09.2024 - 06:00
Pro Research: Wall Street dives into Apple's diverse prospects
24.09.2024 - 06:00
Asian stocks rise on China stimulus cheer; Australia lags before RBA
24.09.2024 - 06:00
Salesforce CTO Harris Parker sells shares worth over $249k
24.09.2024 - 05:00
Pro Research: Wall Street deep dive into Nike's market dynamics
24.09.2024 - 05:00
Avidity Biosciences CFO sells over $500k in company stock
24.09.2024 - 05:00
Salesforce executive sells over $1.5m in company stock
24.09.2024 - 05:00
American Eagle Outfitters exec chairman sells over $20 million in stock
24.09.2024 - 05:00
Avidity Biosciences executive sells over $1 million in company stock
24.09.2024 - 05:00
Salesforce executive sells over $17k in company stock
24.09.2024 - 05:00
Avidity Biosciences CEO sells over $1.4 million in company stock
24.09.2024 - 05:00

© Analytic DC. All Rights Reserved.

new
Огляд ринку Ділова активність у США у вересні залишилася стабільною, але ціновий тиск посилюється
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.